Immediate Impact
3 by Nobel laureates 10 from Science/Nature 59 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout
Works of Christian Scheffold being referenced
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
2022
397 Phase 2 results of XL184 in a cohort of patients (pts) with advanced non-small cell lung cancer (NSCLC)
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Christian Scheffold | 991 | 1022 | 865 | 74 | 2.2k | |
| Thomas A. Puchalski | 822 | 1523 | 895 | 50 | 2.8k | |
| Susan C. Guba | 764 | 1288 | 658 | 49 | 2.3k | |
| Irene Braña | 581 | 1236 | 1241 | 134 | 2.5k | |
| Alison M. Schram | 841 | 1048 | 1034 | 89 | 2.8k | |
| Todd Hembrough | 512 | 859 | 924 | 70 | 2.2k | |
| Ki Y. Chung | 696 | 1601 | 606 | 61 | 2.3k | |
| Heike Richly | 719 | 1135 | 1059 | 56 | 2.3k | |
| Wael A. Harb | 740 | 1366 | 903 | 117 | 2.4k | |
| Marta Salido | 747 | 1253 | 694 | 110 | 2.4k | |
| Iacopo Petrini | 695 | 985 | 861 | 88 | 2.4k |
All Works
Loading papers...